{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:45:10Z","timestamp":1791924310732,"version":"4.3.4"},"reference-count":101,"publisher":"American Chemical Society (ACS)","issue":"40","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sphingolipids regulate membrane organization, cell fate, and immune signaling in both health and disease. Dysregulation of the ceramide, sphingomyelin, and sphingosine-1-phosphate (S1P) pathways contribute to neuroinflammation, neurodegeneration, vascular injury, and cancer, motivating the development of in vivo imaging approaches to quantify sphingolipid signaling. Cellular homeostasis depends on a tightly regulated balance between pro-apoptotic ceramide and pro-survival S1P. Disruption of this balance, particularly through increased sphingosine kinase 1 (SPHK1\/SK1) expression has been linked to aggressive tumor phenotypes and poor clinical outcomes. Recent advances in positron emission tomography (PET) have enabled imaging of select sphingolipid targets, including ceramide transport protein (CERT) and S1P receptor 1 (S1PR1), with one tracer progressing to first-in-human studies. While sphingolipid PET imaging has been applied in Alzheimer\u2019s disease (AD) research, translation to oncology remains limited despite the key role of sphingolipid metabolism in cancer biology and therapy. This review summarizes reported sphingolipid-targeted PET tracers, highlighting their biological rationale, radiochemical development, and preclinical and clinical applications, and emphasizes opportunities to advance sphingolipid PET imaging towards cancer imaging.<\/jats:p>","DOI":"10.1021\/acsomega.6c05504","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:02:22Z","timestamp":1790708542000},"page":"60568-60581","source":"Crossref","is-referenced-by-count":0,"title":["PET Imaging of\nSphingolipid Signaling: Current Radiotracers,\nTranslational Gaps, and Opportunities in Neurodegeneration and Oncology"],"prefix":"10.1021","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4592-0356","authenticated-orcid":true,"given":"Ryan W.","family":"Fitzgerald","sequence":"first","affiliation":[{"name":"Winston-Salem State University , , , ,","place":["Winston-Salem, North Carolina, United States, 27110"]},{"name":"Wake Forest University School of Medicine , , , ,","place":["Winston-Salem, North Carolina, United States, 27157"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6760-607X","authenticated-orcid":true,"given":"Paul Josef","family":"Myburgh","sequence":"additional","affiliation":[{"name":"Wake Forest University School of Medicine , , , ,","place":["Winston-Salem, North Carolina, United States, 27157"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6442-5169","authenticated-orcid":true,"given":"Kiran K.","family":"Solingapuram Sai","sequence":"additional","affiliation":[{"name":"Wake Forest University School of Medicine , , , ,","place":["Winston-Salem, North Carolina, United States, 27157"]},{"name":"Wake Forest University School of Medicine , , , ,","place":["Winston-Salem, North Carolina, United States, 27157"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"issue":"3","key":"2026101315070930200_cit1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2023.151337","article-title":"Ceramides and ceramide synthases in cancer: Focus on\napoptosis and autophagy","volume":"102","author":"Alizadeh","year":"2023","journal-title":"Eur. J. Cell Biol."},{"issue":"11","key":"2026101315070930200_cit2","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1007\/s10495-024-02002-y","article-title":"Sphingolipid metabolism\nand regulated cell death in malignant melanoma","volume":"29","author":"Yan","year":"2024","journal-title":"Apoptosis"},{"key":"2026101315070930200_cit3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/bs.ircmb.2020.02.004","article-title":"On the role\nof sphingolipids in cell\nsurvival and death","volume":"351","author":"Iessi","year":"2020","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"2026101315070930200_cit4","article-title":"Cell death\/survival\nsignal by ceramide and sphingosine-1-phosphate","volume-title":"Glycoscience Pro-Tocols (GlycoPODv2)","author":"Kitatani","year":"2022"},{"issue":"3","key":"2026101315070930200_cit5","doi-asserted-by":"publisher","DOI":"10.12997\/jla.2020.9.3.380","article-title":"Ceramide\/sphingomyelin rheostat regulated by sphingomyelin\nsynthases and chronic diseases in murine models","volume":"9","author":"Taniguchi","year":"2020","journal-title":"J. Lipid Atheroscler."},{"issue":"5","key":"2026101315070930200_cit6","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3978\/j.issn.2218-676X.2015.10.01","article-title":"Ceramide\nand sphingosine-1-phosphate in cancer, two faces of the sphinx","volume":"4","author":"Espaillat","year":"2015","journal-title":"Transl. Cancer Res."},{"issue":"1","key":"2026101315070930200_cit7","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511X-9-15","article-title":"Ceramide and\nceramide 1-phosphate in health and disease","volume":"9","author":"Arana","year":"2010","journal-title":"Lipids Health Dis."},{"key":"2026101315070930200_cit8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2025.100813","article-title":"The bioactive sphingolipid\nplaybook. A primer for the uninitiated as well as sphingolipidologists","volume":"66","author":"Hannun","year":"2025","journal-title":"J. Lipid Res."},{"issue":"8","key":"2026101315070930200_cit9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082062","article-title":"Inhibitors of ceramide-and\nsphingosine-metabolizing\nenzymes as sensitizers in radiotherapy and chemotherapy for head and\nneck squamous cell carcinoma","volume":"12","author":"Yura","year":"2020","journal-title":"Cancers"},{"key":"2026101315070930200_cit10","first-page":"449","article-title":"Activation of sphingosine\n1-phosphate receptor-1 by SEW2871 improves cognitive function in Alzheimer\u2019s\ndisease model rats","volume":"12","author":"Asle-Rousta","year":"2013","journal-title":"EXCLI J."},{"issue":"17","key":"2026101315070930200_cit11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179697","article-title":"Ceramide acyl chain\nlength and its\nrelevance to intracellular lipid regulation","volume":"23","author":"Ho","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"2026101315070930200_cit12","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1053\/j.gastro.2017.10.050","article-title":"Nanoliposome\nC6-ceramide increases the anti-tumor immune response and slows growth\nof liver tumors in mice","volume":"154","author":"Li","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"2026101315070930200_cit13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc3398","article-title":"Ceramide-orchestrated\nsignalling in cancer cells","volume":"13","author":"Morad","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"2026101315070930200_cit14","doi-asserted-by":"publisher","DOI":"10.3390\/jfb13030111","article-title":"Synthesis and characterization of ceramide-containing\nliposomes as membrane models for different T cell subpopulations","volume":"13","author":"Eder","year":"2022","journal-title":"J. Funct. Biomater."},{"issue":"40","key":"2026101315070930200_cit15","doi-asserted-by":"publisher","first-page":"13339","DOI":"10.1002\/anie.201807497","article-title":"A click cage: organelle-specific\nuncaging of lipid messengers","volume":"57","author":"Wagner","year":"2018","journal-title":"Angew. Chem.,\nInt. Ed."},{"issue":"11","key":"2026101315070930200_cit16","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1002\/ejoc.200200518","article-title":"Bioorganic chemistry of ceramide","volume":"2003","author":"Brodesser","year":"2003","journal-title":"Eur. J. Org. Chem."},{"issue":"1","key":"2026101315070930200_cit17","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03221-8","article-title":"The emerging roles of sphingosine 1-phosphate and SphK1\nin cancer resistance: a promising therapeutic target","volume":"24","author":"Alkafaas","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"52","key":"2026101315070930200_cit18","doi-asserted-by":"publisher","first-page":"37355","DOI":"10.1074\/jbc.M113.494740","article-title":"A metabolic\nshift favoring sphingosine 1-phosphate\nat the expense of ceramide controls glioblastoma angiogenesis","volume":"288","author":"Abuhusain","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"7","key":"2026101315070930200_cit19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrc2875","article-title":"Sphingosine 1-phosphate and cancer","volume":"10","author":"Pyne","year":"2010","journal-title":"Nat. Rev.\nCancer"},{"issue":"1","key":"2026101315070930200_cit20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10549-007-9836-9","article-title":"Microarray analysis\nof altered sphingolipid metabolism reveals prognostic significance\nof sphingosine kinase 1 in breast cancer","volume":"112","author":"Ruckha\u0308berle","year":"2008","journal-title":"Breast\nCancer Res. Treat."},{"issue":"18","key":"2026101315070930200_cit21","first-page":"5962","article-title":"Discovery and evaluation\nof inhibitors of human sphingosine kinase","volume":"63","author":"French","year":"2003","journal-title":"Cancer\nRes."},{"issue":"19","key":"2026101315070930200_cit22","doi-asserted-by":"publisher","first-page":"7211","DOI":"10.1128\/MCB.02341-05","article-title":"Intracellular role for\nsphingosine kinase 1 in intestinal adenoma cell proliferation","volume":"26","author":"Kohno","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"2026101315070930200_cit23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5772\/66359","article-title":"Sphingolipid in lung cancer\npathogenesis and therapy","volume-title":"A Global Scientific\nVision - Prevention, Diagnosis, and Treatment of Lung Cancer","author":"Bieberich","year":"2017"},{"issue":"7","key":"2026101315070930200_cit24","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1158\/1078-0432.CCR-10-0720","article-title":"Sphingosine kinase-1 enhances resistance to apoptosis\nthrough activation of PI3K\/Akt\/NF-\u03baB pathway in human non\u2013small\ncell lung cancer","volume":"17","author":"Song","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"21","key":"2026101315070930200_cit25","doi-asserted-by":"publisher","first-page":"6996","DOI":"10.1158\/1078-0432.CCR-08-0754","article-title":"Clinical significance\nof sphingosine kinase-1 expression in human astrocytomas progression\nand overall patient survival","volume":"14","author":"Li","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"2026101315070930200_cit26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1097\/01.jnen.0000175329.59092.2c","article-title":"Sphingosine kinase-1 expression correlates\nwith poor survival of patients with glioblastoma multiforme: roles\nof sphingosine kinase isoforms in growth of glioblastoma cell lines","volume":"64","author":"Van Brocklyn","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"26","key":"2026101315070930200_cit27","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1182\/blood.2021013277","article-title":"Ceramide-induced integrated\nstress response overcomes Bcl-2 inhibitor resistance in acute myeloid\nleukemia","volume":"139","author":"Lewis","year":"2022","journal-title":"Blood"},{"issue":"1","key":"2026101315070930200_cit28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/ijc.29362","article-title":"Sphingosine\nkinase 1 as a potential therapeutic target\nin epithelial ovarian cancer","volume":"137","author":"Lee","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"9","key":"2026101315070930200_cit29","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0964-4","article-title":"Ceramide\nsynthase-6 confers resistance to chemotherapy by binding to CD95\/Fas\nin T-cell acute lymphoblastic leukemia","volume":"9","author":"Verlekar","year":"2018","journal-title":"Cell\nDeath Dis."},{"issue":"6","key":"2026101315070930200_cit30","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3012","article-title":"PP2A inhibition determines\npoor outcome and doxorubicin resistance in early breast cancer and\nits activation shows promising therapeutic effects","volume":"6","author":"Rinco\u0301n","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"2026101315070930200_cit31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/emmm.201201283","article-title":"Sphingosine analogue drug FTY720 targets I2PP2A\/SET\nand mediates lung tumour suppression via activation of PP2A-RIPK1-dependent\nnecroptosis","volume":"5","author":"Saddoughi","year":"2013","journal-title":"EMBO Mol. Med."},{"issue":"11","key":"2026101315070930200_cit32","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nrd3248","article-title":"Fingolimod (FTY720):\ndiscovery and development of an oral drug to treat multiple sclerosis","volume":"9","author":"Brinkmann","year":"2010","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"3","key":"2026101315070930200_cit33","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.pharmthera.2005.05.002","article-title":"FTY720, a\nnew class of immunomodulator, inhibits lymphocyte egress from secondary\nlymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate\nreceptors","volume":"108","author":"Chiba","year":"2005","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"2026101315070930200_cit34","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1056\/NEJMra0708126","article-title":"Malignant gliomas in\nadults","volume":"359","author":"Wen","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"2026101315070930200_cit35","doi-asserted-by":"publisher","first-page":"6915","DOI":"10.1158\/0008-5472.CAN-09-0664","article-title":"Targeting\nsphingosine kinase 1 inhibits\nAkt signaling, induces apoptosis, and suppresses growth of human glioblastoma\ncells and xenografts","volume":"69","author":"Kapitonov","year":"2009","journal-title":"Cancer Res."},{"issue":"1","key":"2026101315070930200_cit36","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9966000","article-title":"The SP\/NK1R\nSystem-Mediated ROS Generation in GBM Cells through Inhibiting Glutaredoxin\nProtein","volume":"2021","author":"Mehrabani","year":"2021","journal-title":"Neurol. Res. Int."},{"issue":"2","key":"2026101315070930200_cit37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/glia.10087","article-title":"Ceramide levels\nare inversely associated with malignant progression of human glial\ntumors","volume":"39","author":"Riboni","year":"2002","journal-title":"Glia"},{"issue":"2","key":"2026101315070930200_cit38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15020479","article-title":"Sphingosine-1-phosphate recruits macrophages\nand microglia and induces a pro-tumorigenic phenotype that favors\nglioma progression","volume":"15","author":"Arseni","year":"2023","journal-title":"Cancers"},{"issue":"9","key":"2026101315070930200_cit39","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41591-018-0135-2","article-title":"Sequestration of T cells\nin bone marrow in the setting of glioblastoma and other intracranial\ntumors","volume":"24","author":"Chongsathidkiet","year":"2018","journal-title":"Nat. Med."},{"issue":"7","key":"2026101315070930200_cit40","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1158\/1541-7786.MCR-12-0600","article-title":"Bioactive lipids S1P and C1P are prometastatic factors\nin human rhabdomyosarcoma, and their tissue levels increase in response\nto radio\/chemotherapy","volume":"11","author":"Schneider","year":"2013","journal-title":"Mol. Cancer Res."},{"issue":"4","key":"2026101315070930200_cit41","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.cellsig.2007.12.008","article-title":"Ceramide 1-phosphate\nstimulates macrophage\nproliferation through activation of the PI3-kinase\/PKB, JNK and ERK1\/2\npathways","volume":"20","author":"Gangoiti","year":"2008","journal-title":"Cell. Signalling"},{"key":"2026101315070930200_cit42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.bcp.2015.12.009","article-title":"Ceramide 1-phosphate\nregulates cell migration and invasion of human pancreatic cancer cells","volume":"102","author":"Rivera","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"2026101315070930200_cit43","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1249929","article-title":"Biology of\nGD2 ganglioside: implications\nfor cancer immunotherapy","volume":"14","author":"Machy","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"1","key":"2026101315070930200_cit44","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1146\/annurev-bioeng-071114-040723","article-title":"Positron emission tomography:\ncurrent challenges and\nopportunities for technological advances in clinical and preclinical\nimaging systems","volume":"17","author":"Vaquero","year":"2015","journal-title":"Annu. Rev. Biomed. Eng."},{"issue":"11","key":"2026101315070930200_cit45","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1021\/acsptsci.3c00200","article-title":"Development and Optimization of 11C-Labeled Radiotracers:\nA Review of the Modern Quality Control Design Process","volume":"6","author":"Myburgh","year":"2023","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"11","key":"2026101315070930200_cit46","doi-asserted-by":"publisher","DOI":"10.3390\/mi8110337","article-title":"Recent\nProgress toward Microfluidic\nQuality Control Testing of Radiopharmaceuticals","volume":"8","author":"Ha","year":"2017","journal-title":"Micromachines"},{"issue":"7","key":"2026101315070930200_cit47","first-page":"1154","article-title":"PET and\ndrug research and development","volume":"40","author":"Fowler","year":"1999","journal-title":"J. Nucl. Med."},{"issue":"Supplement 1","key":"2026101315070930200_cit48","doi-asserted-by":"publisher","first-page":"46S","DOI":"10.2967\/jnumed.123.266978","article-title":"The role of total-body PET in drug\ndevelopment and evaluation: status\nand outlook","volume":"65","author":"Meng","year":"2024","journal-title":"J. Nucl. Med."},{"issue":"1","key":"2026101315070930200_cit49","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11307-024-01979-x","article-title":"PET\nImaging of Sphingosine-1-Phosphate Receptor\n1 with [(18)F]TZ4877 in Nonhuman Primates","volume":"27","author":"Gu","year":"2025","journal-title":"Mol.\nImaging Biol."},{"issue":"3","key":"2026101315070930200_cit50","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3233\/JAD-161231","article-title":"Synthesis,\nRadiosynthesis, and Preliminary\nin vitro and in vivo Evaluation of the Fluorinated Ceramide Trafficking\nInhibitor (HPA-12) for Brain Applications","volume":"60","author":"Crivelli","year":"2017","journal-title":"J.\nAlzheimer\u2019s Dis."},{"issue":"11","key":"2026101315070930200_cit51","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.2967\/jnumed.121.263189","article-title":"Phase 1 Evaluation of (11)C-CS1P1 to Assess\nSafety and Dosimetry in Human Participants","volume":"63","author":"Brier","year":"2022","journal-title":"J. Nucl. Med."},{"key":"2026101315070930200_cit52","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/346783","article-title":"Ceramides\nin Alzheimer\u2019s disease:\nkey mediators of neuronal apoptosis induced by oxidative stress and\nA\u03b2 accumulation","volume":"2015","author":"Jembrek","year":"2015","journal-title":"Oxid. Med. Cell. Longevity"},{"issue":"8","key":"2026101315070930200_cit53","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.1007\/s12035-018-1448-3","article-title":"The role\nof ceramide and sphingosine-1-phosphate in Alzheimer\u2019s disease\nand other neurodegenerative disorders","volume":"56","author":"Czubowicz","year":"2019","journal-title":"Mol.\nNeurobiol."},{"issue":"2","key":"2026101315070930200_cit54","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.chembiol.2023.10.021","article-title":"A bidirectional\nlink between sulfatide and Alzheimer\u2019s disease","volume":"31","author":"Zimmer","year":"2024","journal-title":"Cell Chem. Biol."},{"issue":"1","key":"2026101315070930200_cit55","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/S0197-4580(98)00032-3","article-title":"GM1 ganglioside-bound\namyloid \u03b2-protein in Alzheimer\u2019s\ndisease brain","volume":"19","author":"Yanagisawa","year":"1998","journal-title":"Neurobiol. Aging"},{"issue":"7","key":"2026101315070930200_cit56","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1212\/WNL.0b013e318264e380","article-title":"Serum ceramides increase the risk\nof Alzheimer disease:\nthe Women\u2019s Health and Aging Study II","volume":"79","author":"Mielke","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"2026101315070930200_cit57","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1021\/acschemneuro.6b00391","article-title":"Delineating\namyloid plaque associated neuronal sphingolipids in transgenic Alzheimer\u2019s\ndisease mice (tgArcSwe) using MALDI imaging mass spectrometry","volume":"8","author":"Kaya","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"5","key":"2026101315070930200_cit58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125597","article-title":"Sphingolipid\nmetabolism correlates with cerebrospinal\nfluid Beta amyloid levels in Alzheimer\u2019s disease","volume":"10","author":"Fonteh","year":"2015","journal-title":"PLoS One"},{"issue":"s2","key":"2026101315070930200_cit59","doi-asserted-by":"publisher","first-page":"S231","DOI":"10.3233\/JAD-2012-111727","article-title":"Triangulated mal-signaling in Alzheimer\u2019s disease:\nroles of neurotoxic ceramides, ER stress, and insulin resistance reviewed","volume":"30","author":"de la Monte","year":"2012","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"2026101315070930200_cit60","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1348410","article-title":"A review of the mechanisms of abnormal ceramide metabolism in type\n2 diabetes mellitus, Alzheimer\u2019s disease, and their co-morbidities","volume":"15","author":"Pan","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"12","key":"2026101315070930200_cit61","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1089\/ars.2011.4173","article-title":"Mitochondrion-derived\nreactive oxygen species\nlead to enhanced amyloid beta formation","volume":"16","author":"Leuner","year":"2012","journal-title":"Antioxid.\nRedox Signaling"},{"issue":"1","key":"2026101315070930200_cit62","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-022-04011-6","article-title":"Multi-Omic analyses\ncharacterize the ceramide\/sphingomyelin\npathway as a therapeutic target in Alzheimer\u2019s disease","volume":"5","author":"Baloni","year":"2022","journal-title":"Commun. Biol."},{"issue":"1","key":"2026101315070930200_cit63","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-026-01263-5","article-title":"Inhibition\nof de novo ceramide synthesis mitigates\nalpha-synuclein pathology in a Parkinson\u2019s disease mouse model","volume":"12","author":"Lee","year":"2026","journal-title":"npj Parkinson\u2019s Dis."},{"issue":"1","key":"2026101315070930200_cit64","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1124\/jpet.109.163444","article-title":"Pharmacology and antitumor activity\nof ABC294640, a\nselective inhibitor of sphingosine kinase-2","volume":"333","author":"French","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9","key":"2026101315070930200_cit65","first-page":"3573","article-title":"Targeting ovarian\ncancer and chemoresistance through selective inhibition of sphingosine\nkinase-2 with ABC294640","volume":"33","author":"White","year":"2013","journal-title":"Anticancer Res."},{"key":"2026101315070930200_cit66","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2018.06","article-title":"Sphingolipid metabolism and drug\nresistance in ovarian cancer","volume":"1","author":"Kreitzburg","year":"2018","journal-title":"Cancer Drug Resist."},{"issue":"8","key":"2026101315070930200_cit67","doi-asserted-by":"publisher","first-page":"753","DOI":"10.7164\/antibiotics.53.753","article-title":"B-5354a, b and c, new sphingosine kinase inhibitors,\nproduced by a marine bacterium; taxonomy, fermentation, isolation,\nphysico-chemical properties and structure determination","volume":"53","author":"Kono","year":"2000","journal-title":"J. Antibiot."},{"issue":"7","key":"2026101315070930200_cit68","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1158\/1535-7163.MCT-07-2322","article-title":"Chemosensitizing\neffects of sphingosine kinase-1 inhibition in prostate cancer cell\nand animal models","volume":"7","author":"Pchejetski","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"44","key":"2026101315070930200_cit69","doi-asserted-by":"publisher","first-page":"76921","DOI":"10.18632\/oncotarget.20217","article-title":"Ceramide-containing liposomes with doxorubicin: time and cell-dependent\neffect of C6 and C12 ceramide","volume":"8","author":"\u00d8verbye","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"2026101315070930200_cit70","doi-asserted-by":"publisher","first-page":"459","DOI":"10.7164\/antibiotics.53.459","article-title":"F-12509A,\na new sphingosine kinase inhibitor, produced by a discomycete","volume":"53","author":"Kono","year":"2000","journal-title":"J. Antibiot."},{"issue":"5","key":"2026101315070930200_cit71","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/leu.2008.95","article-title":"Sphingosine\nkinase-1 is a downstream regulator of imatinib-induced apoptosis in\nchronic myeloid leukemia cells","volume":"22","author":"Bonhoure","year":"2008","journal-title":"Leukemia"},{"issue":"22","key":"2026101315070930200_cit72","doi-asserted-by":"publisher","first-page":"9310","DOI":"10.1021\/jm401399c","article-title":"Structure\u2013activity relationships\nand molecular modeling of sphingosine kinase inhibitors","volume":"56","author":"Baek","year":"2013","journal-title":"J. Med. Chem."},{"issue":"8","key":"2026101315070930200_cit73","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1158\/1078-0432.CCR-10-2323","article-title":"A phase\nI clinical trial of safingol\nin combination with cisplatin in advanced solid tumors","volume":"17","author":"Dickson","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"2026101315070930200_cit74","first-page":"5962","article-title":"Discovery and evaluation\nof inhibitors of human sphingosine kinase","volume":"63","author":"French","year":"2003","journal-title":"Cancer\nRes."},{"issue":"7","key":"2026101315070930200_cit75","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1111\/cas.14453","article-title":"Human alkaline\nceramidase 2 promotes the growth, invasion, and migration of hepatocellular\ncarcinoma cells via sphingomyelin phosphodiesterase acid-like 3B","volume":"111","author":"Liu","year":"2020","journal-title":"Cancer Sci."},{"issue":"1","key":"2026101315070930200_cit76","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1042\/BJ20111929","article-title":"Modulation of cellular S1P levels with a novel,\npotent and specific inhibitor of sphingosine kinase-1","volume":"444","author":"Schnute","year":"2012","journal-title":"Biochem. J."},{"issue":"8","key":"2026101315070930200_cit77","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1111\/j.1349-7006.2012.02335.x","article-title":"Sphingosine kinase-1\ninhibition sensitizes curcumin-induced growth\ninhibition and apoptosis in ovarian cancer cells","volume":"103","author":"Yang","year":"2012","journal-title":"Cancer Sci."},{"issue":"8","key":"2026101315070930200_cit78","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1158\/1078-0432.CCR-14-2031","article-title":"Anti-S1P\nantibody as a novel therapeutic strategy\nfor VEGFR TKI-resistant renal cancer","volume":"21","author":"Zhang","year":"2015","journal-title":"Clin.\nCancer Res."},{"issue":"4","key":"2026101315070930200_cit79","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/cncr.30393","article-title":"A phase 2 study\nof the sphingosine-1-phosphate antibody\nsonepcizumab in patients with metastatic renal cell carcinoma","volume":"123","author":"Pal","year":"2017","journal-title":"Cancer"},{"issue":"11","key":"2026101315070930200_cit80","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1194\/jlr.M900048-JLR200","article-title":"Production and characterization of\nmonoclonal anti-sphingosine-1-phosphate antibodies","volume":"50","author":"O\u2019Brien","year":"2009","journal-title":"J. Lipid Res."},{"key":"2026101315070930200_cit81","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.916693","article-title":"ImmunoPET:\nantibody-based\nPET imaging in solid tumors","volume":"9","author":"Manafi-Farid","year":"2022","journal-title":"Front. Med."},{"issue":"3","key":"2026101315070930200_cit82","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2967\/jnumed.107.047787","article-title":"Recommendations on the use of 18F-FDG PET in oncology","volume":"49","author":"Fletcher","year":"2008","journal-title":"J. Nucl. Med."},{"issue":"9","key":"2026101315070930200_cit83","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrc882","article-title":"Molecular\nimaging of cancer with positron emission tomography","volume":"2","author":"Gambhir","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"2026101315070930200_cit84","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S1474-4422(14)70252-2","article-title":"Tau imaging: early\nprogress and future directions","volume":"14","author":"Villemagne","year":"2015","journal-title":"Lancet Neurol."},{"issue":"1","key":"2026101315070930200_cit85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ynirp.2025.100245","article-title":"Radiation-induced brain injury in non-human primates:\nA dual tracer PET study with [11C]MPC-6827 and [11C]PiB","volume":"5","author":"Damuka","year":"2025","journal-title":"NeuroImage:Rep."},{"issue":"3","key":"2026101315070930200_cit86","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging\nbrain amyloid\nin Alzheimer\u2019s disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann. Neurol."},{"issue":"1","key":"2026101315070930200_cit87","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2967\/jnumed.116.184028","article-title":"Total-body PET: maximizing sensitivity to create new\nopportunities for clinical research and patient care","volume":"59","author":"Cherry","year":"2018","journal-title":"J. Nucl. Med."},{"issue":"7","key":"2026101315070930200_cit88","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.1021\/acs.jmedchem.2c01752","article-title":"Discovery of a Promising Fluorine-18\nPositron Emission Tomography Radiotracer for Imaging Sphingosine-1-Phosphate\nReceptor 1 in the Brain","volume":"66","author":"Qiu","year":"2023","journal-title":"J. Med. Chem."},{"key":"2026101315070930200_cit89","unstructured":"Wang, L.; Qiu, Y.; Bi, L.; Huang, G.; Ye, P.; Li, S.; Hongjun, J.\n          Molecular\nImaging of Sphingosine-1-phosphate Receptor 1 via PET Tracer [18F]-TZ4877\nin Response to Electro-puncture Treatment for Alzheimer\u2019s disease\n          J. Nucl. Med.\n          2023; Vol. 64."},{"issue":"8","key":"2026101315070930200_cit90","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/jlcr.3055","article-title":"19F\/18F exchange\nsynthesis for a\nnovel [18F]S1P3-radiopharmaceutical","volume":"56","author":"Rokka","year":"2013","journal-title":"J. Labelled\nCompd. Radiopharm."},{"issue":"13","key":"2026101315070930200_cit91","doi-asserted-by":"publisher","first-page":"6201","DOI":"10.1021\/acs.jmedchem.6b00390","article-title":"Design, Synthesis, and In Vitro and In Vivo Evaluation of an (18)F-Labeled\nSphingosine 1-Phosphate Receptor 1 (S1P1) PET Tracer","volume":"59","author":"Rosenberg","year":"2016","journal-title":"J. Med. Chem."},{"key":"2026101315070930200_cit92","unstructured":"Cai, H.; Ramezani, S.; Christensen, P.; Hao, G.; Sun, X.\n          Copper-64 Labelled Fingolimod for PET\nImaging of the Sphingolipid-1-Phosphate Axis in Prostate Cancer\n          J. Nucl. Med.\n          2015; Vol. 56(s3), , p 1123."},{"key":"2026101315070930200_cit93","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3174\/ajnr.A8944","article-title":"Evaluation of [11C] CS1P1 in Healthy\nYoung and Older Adults","volume":"47","author":"Friedrichsen","year":"2025","journal-title":"Am. J. Neuroradiol."},{"key":"2026101315070930200_cit94","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.apradiso.2019.06.029","article-title":"Automated production\nof a sphingosine-1 phosphate receptor 1 (S1P1) PET radiopharmaceutical\n[11C] CS1P1 for human use","volume":"152","author":"Luo","year":"2019","journal-title":"Appl. Radiat. Isot."},{"issue":"5","key":"2026101315070930200_cit95","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1039\/D1OB02225C","article-title":"Radiosynthesis and\nevaluation of\na fluorine-18 radiotracer [18 F] FS1P1 for imaging sphingosine-1-phosphate\nreceptor 1","volume":"20","author":"Qiu","year":"2022","journal-title":"Org. Biomol. Chem."},{"issue":"1","key":"2026101315070930200_cit96","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76335-4","article-title":"Ceramide\nanalog [18F] F-HPA-12 detects sphingolipid\ndisbalance in the brain of Alzheimer\u2019s disease transgenic mice\nby functioning as a metabolic probe","volume":"10","author":"Crivelli","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"2026101315070930200_cit97","doi-asserted-by":"publisher","DOI":"10.1186\/s41181-021-00149-6","article-title":"EANM guideline\nfor harmonisation on molar activity or specific activity of radiopharmaceuticals:\nimpact on safety and imaging quality","volume":"6","author":"Luurtsema","year":"2021","journal-title":"EJNMMI\nRadiopharm. Chem."},{"key":"2026101315070930200_cit98","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.2147\/DDDT.S170879","article-title":"Copper-64:\na real theranostic agent","volume":"12","author":"Gutfilen","year":"2018","journal-title":"Drug Des., Dev. Ther."},{"issue":"4","key":"2026101315070930200_cit99","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1089\/cbr.2009.0674","article-title":"Copper-64 radiopharmaceuticals for\nPET imaging of cancer:\nadvances in preclinical and clinical research","volume":"24","author":"Anderson","year":"2009","journal-title":"Cancer Biother. Radiopharm."},{"issue":"4","key":"2026101315070930200_cit100","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/cmdc.201000477","article-title":"BZM055,\nan iodinated\nradiotracer candidate for PET and SPECT imaging of myelin and FTY720\nbrain distribution","volume":"6","author":"Briard","year":"2011","journal-title":"ChemMedChem"},{"issue":"3","key":"2026101315070930200_cit101","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/MNM.0b013e3282f3a515","article-title":"PET versus SPECT: strengths,\nlimitations\nand challenges","volume":"29","author":"Rahmim","year":"2008","journal-title":"Nucl. Med. Commun."}],"container-title":["ACS Omega"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsomega.6c05504","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/11\/40\/60568\/68702353\/acsomega.6c05504.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/11\/40\/60568\/68702353\/acsomega.6c05504.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:51:11Z","timestamp":1791921071000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/acsodf\/article\/11\/40\/60568\/5441809\/PET-Imaging-of-Sphingolipid-Signaling-Current"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":101,"journal-issue":{"issue":"40","published-online":{"date-parts":[[2026,9,29]]},"published-print":{"date-parts":[[2026,10,13]]}},"URL":"https:\/\/doi.org\/10.1021\/acsomega.6c05504","relation":{},"ISSN":["2470-1343"],"issn-type":[{"value":"2470-1343","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]}}}